doxorubicina sandoz
sandoz s.p.a. - doxorubicina - doxorubicina
doxorubicina mylan
mylan s.p.a. - doxorubicina - doxorubicina
doxorubicina accord healthcare italia
accord healthcare, s.l.u. - doxorubicina - doxorubicina
doxorubicina aurobindo
eugia pharma (malta) limited - doxorubicina - doxorubicina
doxorubicina esp pharma
esp pharma limited - doxorubicina - doxorubicina
doxorubicina teva
teva italia s.r.l. - doxorubicina - doxorubicina
doxorubicina actavis
actavis group ptc ehf - doxorubicina - doxorubicina
doxorubicina hikma
hikma farmaceutica (portugal) s.a. - doxorubicina - doxorubicina
zolsketil pegylated liposomal
accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doxorubicin - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.
doxorubicin sandoz eco 10 mg/5 ml concentrato per soluzione per infusione
sandoz pharmaceuticals ag - doxorubicini hydrochloridum - concentrato per soluzione per infusione - doxorubicini hydrochloridum 10 mg, natrii chloridum corresp. natrium 17.72 mg, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 5 ml. - farmaco - synthetika